Custodio, Alberto .
HRN: 19-38-61 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/06/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/06/2024
09/14/2024
IV
2.25gm
Q6H
Infected Wound
Waiting Final Action
Indication: Empirical Escalation Type of Infection: PneumoniaSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes